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Abstract
Vitamin D deficiency is associated with osteoporosis and is thought to increase the risk of cancer and CVD. Despite these numerous poten-
tial health effects, data on vitamin D status at the population level and within key subgroups are limited. The aims of the present study were
to examine patterns of 25-hydroxyvitamin D (25(OH)D) levels worldwide and to assess differences by age, sex and region. In a systematic
literature review using the Medline and EMBASE databases, we identified 195 studies conducted in forty-four countries involving more than
168 000 participants. Mean population-level 25(OH)D values varied considerably across the studies (range 4·9–136·2 nmol/l), with 37·3 %
of the studies reporting mean values below 50 nmol/l. The highest 25(OH)D values were observed in North America. Although age-related
differences were observed in the Asia/Pacific and Middle East/Africa regions, they were not observed elsewhere and sex-related differences
were not observed in any region. Substantial heterogeneity between the studies precluded drawing conclusions on overall vitamin D status
at the population level. Exploratory analyses, however, suggested that newborns and institutionalised elderly from several regions world-
wide appeared to be at a generally higher risk of exhibiting lower 25(OH)D values. Substantial details on worldwide patterns of vitamin D
status at the population level and within key subgroups are needed to inform public health policy development to reduce risk for potential
health consequences of an inadequate vitamin D status.
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Vitamin D plays an important role in bone mineralisation
and other metabolic processes in the human body such as
Ca and phosphate homeostasis and skeletal growth(1,2). Vitamin
D deficiency, for example, causes rickets in children, leading
to skeletal abnormalities, short stature, delayed development
or failure to thrive(3). In adults, low values of vitamin D
are associated with osteomalacia, osteopenia, osteoporosis
and subsequent risk of fractures(1). In addition to beneficial
effects on musculoskeletal health, observational studies
have suggested that low 25-hydroxyvitamin D (25(OH)D)
values are associated with an increased risk for several extra-
skeletal diseases including cancer, infections, autoimmune
diseases and CVD(4). In light of the global ageing population(5),
an almost fourfold increase in osteoporotic hip fractures
since 1990(6) and the possible risk of other chronic diseases,
patterns of low 25(OH)D levels are of substantial public
health interest.
Vitamin D status is traditionally measured through assays of
25(OH)D, the major circulating form of vitamin D(7). Although
25(OH)D levels below 25nmol/l have been associated with
disorders of bone metabolism(8) and are used to indicate severe
vitamin D deficiency, the threshold for defining adequate
stores of vitamin D in humans has not been established clearly(9).
The Institute of Medicine has suggested, for example, that
approximately 97·5% of the population across all age groups
meet their requirements for vitamin D, having serum 25(OH)D
values higher than 50nmol/l(10). However, others consider
25(OH)D values of 75 nmol/l or higher to be adequate(11,12).
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Given the absence of uniformly accepted definitions,
previous reviews have reported substantial variations in the
prevalence of vitamin D deficiency across countries
throughout the world, with estimates ranging from 2 to 90 %
depending on the cut-off value and study population
selected(8,13–16). Insights from these earlier studies are limited,
however, due to a focus on specific geographical regions, age
or risk groups. Moreover, use of a binary approach to define
the presence of vitamin D deficiency in some studies might
have also obscured important relationships with chronic dis-
ease that might exist across a broader spectrum of values.
To provide a basis for future efforts to limit the health
consequences of vitamin D deficiency and insufficiency
worldwide, we conducted a systematic literature review of studies
performed worldwide using continuous values for 25(OH)D to
enable comparisons across studies and between different
subgroups within the population. The specific objective of the
present study, therefore, was to assess vitamin D status across a
range of values at the population level and within key population
subgroups defined by age, sex and region.
Methods
Literature search
We searched the Medline and EMBASE databases for original
articles on vitamin D status in the general population. Keywords
were chosen from the Medical Subject Headings terms and the
EMTREE thesaurus, respectively, using the following search
strategy: (vitamin D/D3 OR 25-hydroxyvitamin D/D3 OR
25(OH)D/D3 OR calcidiol) AND (epidemiologic studies OR
population-based OR population OR survey OR representative
OR cross-sectional OR observational) NOT (dihydroxycholecal-
ciferols OR case reports OR case–control studies OR clinical
trials OR reviews) AND humans. Search terms for vitamin D
included the controlled term ‘vitamin D’ (including calcifediol
and 25-hydroxycholecalciferol) and several free-text terms
taking different notations of 25(OH)D into account.
Articles published in English between 1 January 1990 and
28 February 2011 (date of the final screen) were considered.
We excluded articles published before 1990 because of a
general shift in lifestyle, particularly in industrialised nations
(e.g. spending less time outdoors), that might have affected
mean population-level 25(OH)D values(17). The final screen
produced 2566 hits from both databases after excluding
449 exact duplicates identified using EndNote X6 (Thomson
Reuters). Wherever possible, the methods used in the present
review follow the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) statement(18).
Study selection
Studies were included in the present review if they met the
following criteria defined a priori: (1) outcomes – report of
mean or median plasma level for 25(OH)D; (2) study
participants – randomly selected samples from the general
population as well as subgroups defined by age, sex and
specific areas within a country; (3) study designs – cross-sectional
studies or baseline data from population-based cohorts.
Studies were excluded if vitamin D status was estimated
(e.g. through self-reported nutritional intake) or if data were
available only on vitamin D2. We also did not consider studies
using a binary indicator for vitamin D deficiency or insuffi-
ciency as the sole outcome measure, given differing
thresholds used in the literature to define either state(5). Fur-
thermore, clinical samples or studies restricted to subgroups
with specific characteristics (e.g. ethnicity, job and skin
colour) were excluded, as they were not randomly selected
from the general population.
All studies were independently screened and evaluated for
selection by two of the authors (R. H. and A. F.). Inter-rater agree-
ment was good to moderate, and disagreements were discussed
and resolved by consensus in each case (abstract selection:
k ¼ 0·719; full-text selection: k ¼ 0·544). Following the appli-
cation of exclusion criteria to information contained in the study
abstract, we reduced the 2566 screened records to 601 (Fig. 1);
application of these criteria following review of each full-text
article reduced the pool of potentially eligible articles to 272.
Given the presence of multiple reports based on the same data,
our final analytical sample comprised 195 unique studies. In sev-
eral instances, multiple articles from single studies were retained
for analysis as they provided separate 25(OH)D values for sub-
groups with the characteristics of interest (age, sex and region).
Data extraction, data elements and quality assessment
Each study was evaluated using a standardised data extraction
form. In each case, we assessed a wide range of variables
including vitamin D values, assays used and study character-
istics as well as characteristics of the study population and
method of recruitment. Data from most studies were rep-
resented in the dataset by a single entry for the total study
population. Multiple subentries for a single study were
included if data were presented by age, sex or region. All
25(OH)D values were expressed in nmol/l, following conver-
sion from ng/ml (multiplied by a factor of 2·496) as necessary.
Based on the WHO recommendations, we classified geographi-
cal regions as follows: Latin America; North America; Europe; Asia/
Pacific; Middle East/Africa(19). To determine age-related differ-
ences, we defined four age groups: newborns/infants (0–1
years); children/adolescents (.1–17 years); adults (.17–65
years); elderly (.65 years). In instances where details about age
were not provided, we created a separate category (‘other’).
Where possible, we also distinguished elderly living in nursing
homes (institutionalised elderly) from those living in the
community.
We assessed study quality using data reported in each study
on representativeness, validity and reliability. A study was
considered representative if (1) this feature of the study was
explicitly addressed in the corresponding full-text article or
(2) any statement made by the authors suggested that the
actual sample reflected the target population. A study was
classified as non-representative if the corresponding full-text
article contained information about an existing selection
bias, which might also occur in a randomly selected sample
(e.g. overestimation of females). Measurement validity was
J. Hilger et al.24
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evaluated using information about the 25(OH)D measure (e.g.
participation of the laboratory in the International Vitamin D
Quality Assessment Scheme)(20). Finally, a study was classified
as reliable if the intra- and inter-assay coefficients of variation
were below 10 and 15 %, respectively. In instances where
details about representativeness, validity or reliability were
not provided, we created a separate category (‘unknown’)
for each quality criterion.
Medline
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n 1635
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EMBASE
(1990–2011)
n 1380
Combined
(1990–2011)
n 2566
Records included based
on information
contained in the abstract
n 601
Records included based
on information
contained in the full text
n 272
Unique studies included
in the systematic review
n 195
Studies eligible for
meta-analyses stratified
by age and region
n 112
Studies eligible for
meta-analyses stratified
by sex and region
n 82
Duplicates (n 449)
Reasons for exclusion at this phase of the review:
Reasons for exclusion at this phase of the review:
Reasons for exclusion from meta-analyses:
Reasons for exclusion from meta-
analyses stratified by sex:
No outcome measure of vitamin D (n 857)
Patient population: renal diseases (n 109), orthopaedic
diseases (n 95), thyroid diseases (n 47), CVD
(n 35), cancer (n 35) and other diseases (n 330)
Other selective population, e.g. by ethnicity or job (n 187)
Duplicates (not electronically identified; n 81)
No blood samples (n 59)
Other study designs, e.g. case–control studies or reviews (n 33)
Other reasons (n 97)
No outcome measure of vitamin D (n 164)
Patient population (n 21)
Other reasons (n 65)
Multiple reports on the same data (n 77)
Report of median 25(OH)D values only (n 15)
No standard deviation reported (n 30)
Sample size ≤30 (n 8)
Studies on newborns (n 10)
Studies on institutionalised elderly (n 9)
Other reasons (n 11)
25(OH)D values not reported
separately for males and females (n 30)
Other study designs, e.g. case–control studies or
intervention trials (n 7)
Population subgroup defined by other characteristics,
e.g. ethnicity or job (n 72)
Fig. 1. Flow chart of the study selection (1990–2011). 25(OH)D, 25-Hydroxyvitamin D.
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Table 1. Characteristics and main results from single studies on 25-hydroxyvitamin D (25(OH)D)*
Region and
country
City/region within
the country Reference n Male (%) Age group Season
25(OH)D
(nmol/l) Reliability Representativeness
Europe
Austria
Whole country Koenig & Elmadfa(33) 1452 NA O NA 27·5 Unknown Unknown
Whole country Kudlacek et al.(34) 1048 38·2 A Winter 52·2 Unknown No
Belgium
Brabant Boonen et al.(35) 245 0·0 E NA 56·4 Unknown No
Brussels MacFarlane et al.(36) 126 31·0 A Winter 48·4 Unknown No
Brussels Moreno-Reyes et al.(37) 401 50·1 A NA 35·0 Yes No
Northern Belgium Richart et al.(38) 542 49·8 NA NA 71·4†; 73·4‡ Unknown Unknown
Czech Republic
Prague Zofkova & Hill(39) 47 0·0 A NA 58·2 Unknown No
Denmark
Copenhagen Andersen et al.(40) 112 NA C; E Winter 24·4§; 47·8§ Yes No
Copenhagen Brot et al.(41) 510 0·0 A NA 24·0§ Yes No
Faroe Islands Dalgard et al.(42) 669 51·1 E Mixed 47·6 Unknown Unknown
Odense Frost et al.(43) 700 100·0 A Whole year 64·9 Unknown No
Aarhus Rejnmark et al.(44) 315 0·0 A NA 57·0§ Unknown No
Aarhus Rejnmark et al.(45) 2316 0·0 A Mixed 62·0§ Unknown Yes
Copenhagen Rudnicki et al.(46) 125 42·4 A Whole year 25·5 Yes Yes
Estonia
Vaike-Maarja Kull et al.(47) 367 45·5 A Winter 43·7 Yes Yes
Finland
Porvoo (region) Andersen et al.(40) 120 NA A; E Winter 29·2§; 45·2§ Yes No
Whole country Kauppi et al.(48) 6035 45·3 A NA 45·1†; 45·2‡ Yes No
Whole country Lamberg-Allardt et al.(49) 328 38·4 A Mixed 45·0†; 47·0‡ Yes Unknown
Whole country Matilla et al.(50) 4097 47·0 A Whole year 43·6 Yes Unknown
Whole country Partti et al.(51) 6241 45·0 A Mixed 45·1 Unknown No
North Savo Parviainen et al.(52) 776 53·9 A Mixed 34·0†; 35·0‡ Unknown Unknown
Turku Piirainen et al (53) 82 NA C Mixed 54·7 Unknown Unknown
Helsinki Viljakainen et al.(54) 64 0·0 C Summer; winter 59·5; 37·3 Yes Unknown
Helsinki Viljakainen et al.(55) 125 52·8 I Winter 50·7 Yes Unknown
France
Montpellier Blain et al.(56) 248 0·0 A NA 64·1§ Yes No
Caen Bougle et al.(57) 82 NA I NA 74·9 Unknown No
France Chapuy et al.(58) 1569 48·8 A Winter 61·0 Yes Unknown
Burgundy De Carvalho et al.(59) 164 42·7 A Whole year 74·4†; 52·8‡ Unknown No
Poitiers Deplas et al.(60) 64 31·3 E Spring 21·4 Unknown No
Whole country Malvy et al.(61) 1191 42·7 A Winter 79·5 Unknown Unknown
Germany
Bonn Braemswig et al.(62) 21 100·0 A Mixed 51·3 Unknown Unknown
Whole country Hintzpeter et al.(63) 4030 43·7 O NA 45·2§†; 44·7§‡ Yes Yes
Southern Germany Scharla et al.(64) 415 50·4 A Summer; winter 67·4; 42·4 Yes Unknown
Southern Germany Woitge et al.(65) 41 36·6 O Mixed 65·6 Unknown No
Bonn Zittermann et al.(66) 76 0·0 A Summer; winter 69·8; 30·3 Unknown No
Greece
Athens Nicolaidou et al.(67) 123 57·7 I Whole year 50·9§ Yes Yes
Athens Papapetrou et al.(68) 279 17·2 E Mixed 42·9 Unknown No
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Table 1. Continued
Region and
country
City/region within
the country Reference n Male (%) Age group Season
25(OH)D
(nmol/l) Reliability Representativeness
Iceland
Reykjavik Kristinsson et al.(69) 259 0·0 C Winter 43·9 Yes No
Reykjavik Sigurdsson et al.(70) 308 0·0 E Mixed 53·1 Yes NA
Reykjavik Steingrimsdottir et al.(71) 944 52·0 A Whole year 45·7 Yes No
Ireland
Cork (region) Andersen et al.(40) 62 NA C; E Winter 41·3§; 43·7§ Yes No
Cork (city) Hill et al.(72) 44 0·0 A Winter 54·5 Yes Unknown
Dublin Keane et al (73) 116 NA E NA 37·1 Unknown Unknown
Israel
Whole country Oren et al.(74) 195 48·7 O Whole year 57·2 Unknown Yes
Italy
Whole country Adami et al.(75) 697 0·0 E Winter 37·9 Unknown No
Southern Italy Carnevale et al.(76) 90 35·6 A Winter 42·7 Yes No
Rome Romagnoli et al.(77) 135 NA A Summer; winter 90·1; 45·9 Yes No
Greve, Bagno a Ripoli Vezzoli et al.(78) 595 50·8 O NA 61·2†; 48·2‡ Yes Unknown
Netherlands
Bilthoven, Utrecht Al-Delaimy et al.(79) 65 46·2 A NA 91·2†; 77·2‡ Unknown Unknown
Zutphen Baynes et al.(80) 142 100·0 E Spring 42·0 Yes No
Rotterdam Fang et al.(81) 1317 NA E Whole year 65·5 Yes No
Whole country Kuchuk et al.(82) 1319 48·7 E Whole year 53·2 Yes Yes
Whole country Lo¨wik et al.(83) 529 50·7 E NA 40·0†; 38·0‡ Unknown No
Hoorn Pilz et al.(84) 614 NA E Whole year 56·5†; 50·8‡ Yes No
Amsterdam Van Summeren et al.(85) 307 50·8 C NA 69·6 Unknown No
Norway
Skjervoy Brustad et al.(86) 32 65·6 A NA 67·2 Unknown No
Northern Norway Brustad et al.(87) 300 0·0 A Mixed 56·9 Yes Unknown
Tromso Grimnes et al.(88) 6932 39·0 A NA 58·9 Yes No
Oslo Meyer et al.(89) 869 42·8 A Mixed 74·8 No No
Poland
Sadyba (Warsaw) Andersen et al.(40) 126 NA C; E Winter 30·6§; 32·5§ Yes No
Warsaw Napiorkowska et al.(90) 274 0·0 E Winter 33·7 Yes Yes
Russia
NA Sapir-Koren et al.(91) 122 0·0 E NA 29·1 Unknown No
Spain
Sabadell Almirall et al.(92) 237 46·8 E Winter 42·9 Unknown No
L’Hospitalet de Llobregat Gomez et al.(93) 253 49·8 A Whole year 52·7†; 49·9‡ Unknown Yes
Betanzos Moreiras et al.(94) 55 45·5 E Spring 25·3 Unknown Unknown
Lleida Muray et al.(95) 391 58·1 A Autumn 23·4†; 21·3‡ Unknown No
Murica Perez-Llamas et al.(96) 86 33·7 E Mixed 50·1 Yes Unknown
Sweden
Central Sweden Burgaz et al.(97) 116 0·0 E Winter 69·0 Yes Unknown
Uppsala, Va¨stmanland Burgaz et al.(98) 100 0·0 E Winter 72·0 Unknown No
Malmo Gerdhem et al.(28) 986 0·0 E Whole year 95·0 Yes No
Uppsala Hagstro¨m et al.(99) 958 100·0 E NA 69·0 Unknown Unknown
Uppsala Lind et al.(100) 34 100·0 A NA 90·0 Unknown No
Stockholm Melin et al.(101) 104 22·1 E Spring 69·9†; 64·9‡ Yes No
Stockholm Salminen et al.(102) 350 0·0 E Whole year 91·0§ Yes No
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Table 1. Continued
Region and
country
City/region within
the country Reference n Male (%) Age group Season
25(OH)D
(nmol/l) Reliability Representativeness
Switzerland
Vaud, Fribourg, Ticino Burnand et al.(103) 3276 51·7 O Mixed 50·0 Unknown Yes
Lausanne Krieg et al.(104) 349 29·5 E NA 26·5†; 23·2‡ Unknown Unknown
Basel Theiler et al.(29) 505 57·4 E Mixed 17·5†k; 18·2‡k;
91·6†; 67·4‡
Yes No
UK
Central, South, West
England, Wales
Bates et al.(105) 924 NA E Mixed 51·9 Unknown No
East Kent Carter et al.(106) 188 25·5 E Mixed 31·2§ Unknown No
Northern Ireland Cashman et al.(107) 1015 49·8 C Mixed 61·1†§; 59·0‡§ Yes Yes
Great Britain Davies et al.(108) 756 NA C Mixed 51·8 Unknown Yes
South England Elia et al.(109) 1026 NA E NA 52·5 Unknown No
Isle of Ely Forouhi et al.(110) 524 40·8 A NA 60·2 Yes Unknown
Cambridge Hegarty et al.(111) 96 49·0 E Winter 23·1 Yes Unknown
Northern Ireland Hill et al.(112) 1015 49·8 C Whole year 64·3 Yes Yes
England Hirani & Primatesta(113) 1297 40·3 E Whole year 40·0†k; 37·4‡k
58·3†; 49·4‡
Unknown Yes
Great Britain Hypponen & Power(114) 7437 50·1 A Summer; winter 60·3; 41·1 Yes No
Grampian Macdonald et al.(115) 2905 0·0 A Mixed 53·9 Yes No
Aberdeen Mavroeidi et al.(116) 325 0·0 E Mixed 53·3 No No
Isle of Ely Wareham et al.(117) 1057 43·3 NA Whole year 54·4†; 46·2‡ Yes No
North America
Canada
Quebec Barake et al.(118) 404 51·2 E Mixed 74·0 Yes No
Nunavut El Hayek et al.(119) 282 46·8 C Mixed 48·3§ No Yes
Whole country Langlois et al.(120) 5306 48·4 O Whole year 67·7 Yes Yes
St Theresa Point, Garden Hill Lebrun et al.(121) 76 NA I Summer 26·2 Unknown Unknown
Toronto Liu et al.(122) 155 49·7 E Autumn 44·9 Unknown Unknown
Quebec Mark et al.(123) 1753 50·3 C Mixed 46·0 Yes No
Avalon Peninsula Newhook et al.(124) 51 NA I Summer; winter 63·6; 48·6 Unknown No
Edmonton Overton & Basu(125) 36 100·0 E Summer 122·0 Unknown No
Calgary Rucker et al.(126) 188 31·9 E Winter 57·3 No No
Quebec Sinotte et al.(127) 741 0·0 A Winter 64·9 Yes No
USA
NA Alvarez et al.(128) 50 0·0 A Mixed 55·7 Unknown No
New York Arunabh et al.(129) 410 0·0 A Whole year 54·2 Yes No
Connecticut Avery et al.(130) 114 NA E NA 113·1; 81·8k Yes No
Honolulu Chai et al.(131) 182 0·0 A NA 72·3 Unknown Unknown
Framingham Cheng et al.(132) 3890 46·0 A Whole year 92·9 No No
Boston Dawson-Hughes et al.(133) 391 46·5 E Whole year 82·4†; 68·9‡ Yes Unknown
Oakland Dror et al.(134) 199 NA I Mixed 43·7 Unknown Unknown
Whole country Looker et al.(135) 18462 47·2 O Summer, winter 77·3; 67·2 No Yes
Framingham Hannan et al.(136) 341 NA E NA 71·9 Yes No
Boston, Houston, West
Lafayette
Hill et al.(137) 735 30·5 C NA 66·2 Unknown Unknown
Whole country Iannuzzi-Sucich et al.(138) 337 42·1 E NA 67·4†; 57·7‡ Yes No
Connecticut Ilich et al.(139) 136 0·0 E Whole year 52·8 Unknown No
Framingham Jaques et al.(140) 759 38·2 E NA 82·0†; 71·0‡ Yes Unknown
Northern Georgia Johnson et al.(141) 317 20·2 E Whole year 66·7 Yes Unknown
Rochester Khosla et al.(142) 138 0·0 A NA 77·6 Unknown Unknown
Whole country Kim et al.(143) 8351 0·0 O NA 61·0 Unknown No
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Table 1. Continued
Region and
country
City/region within
the country Reference n Male (%) Age group Season
25(OH)D
(nmol/l) Reliability Representativeness
California Kremer et al.(144) 90 0·0 A Summer 75·1 Unknown No
Eastern Nebraska Lappe et al.(145) 1179 0·0 E Whole year 71·8 Yes No
Whole country Mansbach et al.(146) 4558 49·6 C Whole year 68·0 Unknown Yes
Farmington Mirza et al.(147) 40 0·0 A; E NA 74·9; 84·9 Yes No
Rancho Bernardo Reis et al.(148) 654 36·4 E NA 103·6 Yes No
Marion County Rock et al.(149) 1042 39·4 O Mixed 31·9†; 29·3‡ Yes Yes
Greenwich Sabetta et al.(150) 198 42·9 O Autumn 70·9 Unknown Unknown
Framingham Shea et al.(151) 1381 48·4 A NA 49·4 Unknown No
Athens Stein et al.(152) 168 0·0 C Whole year 93·8 Yes No
Bangor Sullivan et al.(153) 22 0·0 C Summer 74·4 Yes Unknown
Philadelphia Weng et al.(154) 382 47·6 C Whole year 69·9§ Yes Yes
Asia/Pacific
Australia
Sydney Bowyer et al.(155) 901 NA I Winter 60·0§ Unknown No
Sydney Brock et al.(156) 186 NA E NA 36·0; 33·0k Yes No
Dubbo Center et al.(157) 437 100·0 E NA 70·7 Yes No
Tasmania Ding et al.(158) 1002 NA A Mixed 52·8 Yes Unknown
North-Western Adelaide Ngo et al.(159) 253 43·5 E NA 72·2 Yes No
Barwon Pasco et al.(160) 861 0·0 A Whole year 70·0 Yes No
Melbourne Stein et al.(161) 99 26·3 E Winter 26·0§ Yes No
Sydney Zochling et al.(162) 584 21·2 E Mixed 21·4†; 16·9‡ Unknown No
China
Linxian Abnet et al.(163) 720 42·2 A Spring 33·1 Yes Unknown
Hong Kong Chan et al.(164) 53 0·0 E NA 57·7 Unknown No
Linxian Chen et al.(165) 2018 54·0 A Spring 31·7 Unknown Unknown
Beijing Du et al.(166) 649 0·0 C Winter 33·5 Yes Yes
Shanxi Strand et al.(167) 250 52·4 C Spring 42·3†; 25·5‡ Unknown Unknown
Taipei Tsai et al.(168) 262 0·0 A Mixed 76·6 Yes No
Fiji Islands
Whole country Heere et al.(169) 511 0·0 A Winter 76·0 Unknown Unknown
India
Agota Goswami et al.(170) 57 56·1 A Winter 36·4 Unknown Unknown
Tirupati Harinarayan et al.(171) 1146 21·2 A NA 46·3†; 38·7‡ Unknown No
Lucknow Sachan et al.(172) 117 NA I Mixed 21·0 Yes No
Indonesia
Jakarta, Bekasi Rinaldi et al.(173) 62 0·0 E Summer 68·2 Unknown Unknown
Jakarta, Bekasi Setiati et al.(174) 74 0·0 E NA 38·7 No Yes
Japan
NA Kuwabra et al.(175) 50 30·0 E NA 27·7§ Unknown Unknown
Tokyo Kwon et al.(176) 1094 41·7 E Winter 71·7†; 65·8‡ Unknown No
Toyosaka Nakamura et al.(177) 160 0·0 E Summer 78·3 Yes No
Toyosaka Nakamura et al.(178) 117 0·0 E Summer 59·1 Yes Yes
Tokyo Suzuki et al.(179) 2957 32·1 E Autumn 71·1†; 60·4‡ Unknown No
Malaysia
Kuala Lumpur Rahman et al.(180) 101 0·0 A NA 44·4 Yes No
Mongolia
Ulaanbaatar Lander et al.(181) 98 72·4 C Autumn 24·1 Yes No
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Table 1. Continued
Region and
country
City/region within
the country Reference n Male (%) Age group Season
25(OH)D
(nmol/l) Reliability Representativeness
New Zealand
Auckland Bolland et al.(182) 1984 19·1 A; E NA 84·0†; 51·0‡ Yes No
Auckland Bolland et al.(183) 116 0·0 A NA 54·0 Unknown Unknown
Auckland Bolland et al.(184) 100 50·0 A; E NA 91·0†; 51·0‡ Yes No
Wellington; Christchurch Camargo et al.(185) 922 50·7 I Whole year 44·0§ Yes Unknown
Auckland Grant et al.(186) 353 47·6 I Whole year 55·0 Yes Unknown
Dunedin Houghton et al.(187) 193 57·5 C Mixed 52·0 Yes Unknown
Auckland Ley et al.(188) 39 0·0 E Winter 26·1 Unknown No
Auckland Lucas et al.(189) 1606 0·0 E Whole year 51·2 Unknown No
Whole country Rockell et al.(190) 1585 50·5 C Mixed 50·0 Yes No
Dunedin; Invercargill Rockell et al.(191) 342 34·8 A Summer 85·0 Unknown Unknown
Auckland Scragg et al.(192) 295 100·0 A Whole year 39·8 No Yes
South Korea
Chungju Kim et al.(193) 1330 38·0 E Whole year 46·1 Unknown No
Seoul Namgung et al.(194) 71 50·7 I Summer; winter 74·9; 26·7 Yes Unknown
Thailand
NA Chailurkit et al.(195) 158 48·7 O NA 168·2†; 105·8‡ Unknown Unknown
Khon Kaen Chailurkit et al.(196) 251 50·2 O NA 128·3†; 93·6‡ No Yes
Bangkok Chailurkit et al.(197) 229 47·2 O NA 135·0†; 72·6‡ No Unknown
Bangkok Chailurkit et al.(26) 446 0·0 E NA 67·6 Yes Unknown
Khon Kaen Soontrapa et al.(198) 65 0·0 E Summer 83·2 No Unknown
Vietnam
Ho Chi Minh (city) Ho-Pham et al.(199) 637 32·2 A Mixed 91·9†; 75·1‡ Yes Yes
Middle East/
Africa
Cameroon
Ntam Njemini et al.(200) 152 60·5 E NA 52·7 Unknown No
Iran
Tehran Bassir et al.(201) 44 NA I Mixed 4·9 Unknown Unknown
Tehran Dahifar et al.(202) 414 0·0 C Mixed 74·9 Unknown Unknown
Tehran Hashemipour et al.(203) 1210 59·1 O NA 20·7§ Yes No
Tehran Hossein-Nezhad et al.(204) 646 24·8 A NA 31·3 Yes Unknown
Tehran Hosseinpanah et al.(205) 245 0·0 A NA 73·0 Yes Yes
Zanjan Kazemi et al.(206) 61 NA I Mixed 16·7 Unknown Unknown
Shiraz Masoompour et al.(207) 520 100·0 A Winter 35·0 Yes Yes
Tehran Mirsaeid Ghazi et al.(208) 1171 41·8 O Mixed 87·4†; 52·4‡ Yes No
Isfahan Moussavi et al.(209) 318 48·1 C Winter 93·1†; 41·8‡ Yes No
Tabriz Niafar et al.(210) 300 0·0 A Mixed 35·4§ Yes Unknown
Tehran Rabbani et al.(211) 963 44·0 C Winter 116·1†; 60·3‡ Yes No
Isfahan Salek et al.(212) 88 NA I Summer 68·4 Yes Unknown
Jordan
Northern Jordan Gharaibeh & Stoecker(22) 186 27·4 A Summer 25·6 Unknown Unknown
Lebanon
NA Arabi et al.(213) 443 64·6 E Spring 28·5 Unknown Unknown
Beirut, Bekaa Gannage-Yared et al.(214) 316 31·3 A Winter 24·2 Yes No
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Statistical analyses
Descriptive statistics were calculated for baseline character-
istics of all the included studies. If mean 25(OH)D values
were not reported in an article, we used median values
(9·2 % of the studies) in our descriptive analyses.
Meta-analyses were performed for subgroups stratified by
age, sex and geographical region using random-effects
models. Studies reporting median 25(OH)D values (n 15) or
mean values without a corresponding standard deviation
(n 30) were not included in this phase of the analyses
(Fig. 1). In addition, our focus in the meta-analyses was
limited to studies/subgroups with sample sizes greater than
30, given concerns about the precision of estimates. Studies
on newborns (n 10) and institutionalised elderly (n 9) were
also not included in the meta-analyses. For analyses stratified
by sex, we also excluded studies that did not report separate
25(OH)D values for males and females (n 30).
Heterogeneity between the studies was assessed by visual
inspection of forest plots and calculation of I 2 statistics. Because
we found substantial heterogeneity across the studies,
we decided to further explore potential explanatory factors.
Therefore, we conducted heterogeneity analyses within each
subgroup by accounting for a range of characteristics other
than age and sex, which included season, assay type, distance
from the equator(5) and components of study quality. Studies
were grouped by study characteristics (e.g. season and assay
type) to assess whether heterogeneity was reduced as indicated
by the I 2 statistics and the inspection of forest plots.
Supplementary analyses explored patterns of vitamin D
status within specific subgroups (e.g. institutionalised elderly)
and for selected associations reported in previous work. The
purpose of these exploratory analyses was to support further
research in this area by generating hypotheses that might be
tested more thoroughly in future studies. All statistical analyses
were conducted using STATA version 12.1 (StataCorp).
Results
Description of studies
Studies included in the present review (Table 1) contained data on
a total of 168389 participants from forty-four countries. The sample
size of individual studies ranged from 11 to 18462 participants with
a median of 316 (interquartile range 117–861). While the majority
of studies contained data on males and females, nine studies
(4·7%) restricted their focus to males, while fifty-four studies
(28·0%) contained data on only females. The overall proportions
of males and females were 33·3 and 66·7%, respectively, and the
mean age of the participants was 51·7 (SD 24·3) years. Most studies
were conducted in Europe (45·1%), followed by the Asia/Pacific
region (23·8%) and NorthAmerica (19·7%). In terms of the country
in which studies were conducted, most were carried out in the
USA (n 28), followed by Iran (n 12), New Zealand (n 11) and
Canada (n 10).
The assays reported to measure 25(OH)D values included
RIA (55·9 %), competitive protein-binding assays (14·0 %)
and other methods such as chemiluminescence immunoassay
and HPLC.T
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In terms of study quality, more than half of the studies (50·2%)
were classified as non-representative of the target population
and 14·9% qualified as representative according to the criteria
defined previously. Evidence of representativeness could not
be established in 34·9% of the studies due to missing infor-
mation. Information on assay reliability was provided in 61·0%
of the studies with 52·8% classified as providing reliable
25(OH)D measurements. Assay validity was reported in a min-
ority of studies (9·7%).
Global vitamin D status
There was a significant variability in the estimates of 25(OH)D
values across the studies with mean and median values
ranging from 4·9 to 136·2 nmol/l and 20·7 to 91·0 nmol/l,
respectively. We found that 88·1% of the samples presented
in the present review had mean 25(OH)D values below
75nmol/l, 37·3% had mean values below 50nmol/l and 6·7%
had mean values below 25nmol/l. Fig. 2 provides an overview
Europe (ninety studies)
Austria (n 2)
Belgium (n 4)
Czech Republic (n 1)
Denmark (n 7)
Estonia (n 1)
Finland (n 9)
France (n 6)
Germany (n 5)
Greece (n 2)
Iceland (n 3)
Ireland (n 3)
Israel (n 1)
Italy (n 4)
Netherlands (n 7)
Norway (n 4)
Poland (n 2)
Russia (n 1)
Spain (n 5)
Sweden (n 7)
Switzerland (n 3)
UK (n 13)
Canada (n 10)
USA (n 28)
Australia (n 8)
China (n 6)
Fiji Islands (n 1)
India (n 3)
Indonesia (n 2)
Japan (n 5)
Malaysia (n 1)
Mongolia (n 1)
New Zealand (n 11)
South Korea (n 2)
Thailand (n 5)
Vietnam (n 1)
Cameroon (n 1)
Gambia (n 1)
Iran (n 12)
Jordan (n 1)
Lebanon (n 2)
Nigeria (n 1)
South Africa (n 1)
Argentina (n 1)
Brazil (n 2)
0 25 50 75 100 125
North America (thirty-eight studies)
Asia Pacific (forty-six studies)
Middle East and Africa (nineteen studies)
South America (three studies)
Fig. 2. Mean/median 25-hydroxyvitamin D (25(OH)D) values, by geographical region and country. Note: medians ( ) are shown where mean values ( ) are not
reported; Study size is indicated by circle size. The background colour scheme is intended to reflect the current uncertainty around the definition of thresholds
for deficient, insufficient and adequate 25(OH)D levels. Mean/median values falling within the intensely red zone are most consistent with severe vitamin D
deficiency; those in the green zone reflect adequate vitamin D levels. Values within the yellow zone are those thought to be indicative of insufficiency. Data from
three studies not indicating geographical region have been excluded(221– 223); data from a single study(40) providing country-specific data on four nations in Europe
are represented separately. One study(195) reported a mean 25(OH)D value of 136·2 nmol/l and therefore is not presented in the figure due to graphical reasons.
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of the distribution of country- and study-specific mean 25(OH)D
values, stratified by region. In addition, a visualisation of the
available data on a global map can be found elsewhere(21).
Vitamin D status by age, sex and region
Due to a limited number of studies being identified from Latin
America, it was not possible to perform meta-analyses for this
region. Depending on the stratifying variable, I 2 values ranged
from 84·5 to 99·7%, indicating substantial heterogeneity between
the studies.
No significant age- or sex-related differences in 25(OH)D
values were observed in the sample of eligible studies world-
wide (data not shown). However, we observed differences
by region with values being significantly higher in North
America than in Europe or the Middle East/Africa region
(Figs. 3–6). In an analysis stratified by age and region, we
did not find age-related differences for Europe and North
America (Table 2). However, in the Asia/Pacific region, chil-
dren/adolescents were found to have significantly lower
25(OH)D values than adults and elderly. In contrast, children/
adolescents from the Middle East/Africa region had signifi-
cantly higher values than the other two age groups. No
significant sex-related differences were observed in any of
the regions (Figs. 3–6). However, reports of 25(OH)D values
in women tended to be lower, especially in the Asia/Pacific
and Middle East/Africa regions.
Heterogeneity analyses
The substantial heterogeneity that we observed within the
different geographical regions could not be explained by the
characteristics of the study population or features of study qual-
ity. Grouping studies by age category and sex, assay type,
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Fig. 3. Forest plot for Europe stratified by sex. ES, effect estimator. (A colour version of this figure can be found online at http://www.journals.cambridge.org/bjn)
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season, distance from the equator or representativeness, for
example, did not significantly reduce heterogeneity across the
studies in our sample, as measured by the I 2 statistics.
Exploratory analyses
We found that mean 25(OH)D values for institutionalised elderly
were lower than those for non-institutionalised elderly,
especially in Europe and the Asia/Pacific region. Moreover, in
specific subgroups in single countrieswithinEurope,weobserved
differences, with Swedish elderly having higher 25(OH)D mean
values than the elderly in other European countries. In addition,
we found that newborns had lower 25(OH)D values than the
other three age groups in several countries worldwide.
Discussion
Summary of the main findings
The published evidence on vitamin D status at the population
level, as assessed by mean or median 25(OH)D values, is
characterised by a high degree of variability across studies,
countries and regions. Although no age- or sex-related signifi-
cant differences in 25(OH)D values were observed across the
sample of studies that we reviewed, we did observe
differences by region with values being significantly higher
in North America than in Europe or the Middle East/Africa
region. In stratified analyses, significant age-related differ-
ences were observed in the Asia/Pacific and Middle East/
Africa regions, but not elsewhere. However, exploratory
analyses suggested that newborns and institutionalised elderly
were more likely to have lower reported 25(OH)D values in
several regions worldwide. We found substantial heterogeneity
between the studies in our sample from each geographical
region that could not be explained in a detailed analysis.
Interpretation and comparison with previous studies
In contrast to previous reviews(5,13,14), we could not find differ-
ences in 25(OH)D values for children/adolescents, adults and
elderly. However, in analyses stratified by geographical
region, significant age-related differences could be observed
for the Asia/Pacific region, with children/adolescents
having lower 25(OH)D values than older groups. This might
be primarily due to the low 25(OH)D values found for Chinese
children/adolescents as reported in previous work(13), who
were observed to have low dietary Ca intake and limited sun-
light exposure as possible reasons. In contrast, in the Middle
East/Africa region, children/adolescents were found to have
significantly higher 25(OH)D values than adults and elderly, a
finding consistent with at least one previous study(8). One
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potential explanation for this pattern in the Middle East/Africa
region could be that children/adolescents from this region gen-
erally spend more time outdoors compared with the other age
groups (e.g. indoor working by the adult population)(22). How-
ever, others have also found age-related differences in other
regions(5,13,14), which could not be confirmed in the present
meta-analyses. A reduction in differences and thus greater simi-
larities across age groups might be attributable to lifestyle
changes over the course of time in which younger individuals
from industrialised countries spend more time indoors
watching television, using computers and playing video
games compared with older adults(23).
In contrast to previous reviews, we were also unable to find
significant sex-related differences(8,13,16). On examining our
data by region, however, we observed that females tended
to have lower 25(OH)D values, especially in the Middle
East/Africa and Asia/Pacific regions. Some have suggested
that this finding may be related to cultural factors such as
differences in clothing styles that may impede vitamin D
conversion in the skin(24).
The highest mean 25(OH)D values were generally observed
in North America, a finding that might be explained by the
routine fortification of several foods (e.g. milk, juice and cer-
eals) in the USA(25). The absence of significant differences
between studies conducted in North America and those car-
ried out in the Asia/Pacific region, however, may have been
influenced by relatively high values found in Thailand, a
country located near the equator with significant year-round
sunlight exposure and higher daytime temperatures, resulting
in the use of lighter-weight clothes, which afford less UV pro-
tection(26). Studies conducted in Japan and other Asian
countries may have further contributed to somewhat higher
regional values, resulting from diets rich in vitamin D foods
such as oily fish(27).
Previous reviews(5,8,15) have reported an apparent north–
south gradient for 25(OH)D in Europe, with Scandinavian
countries showing generally higher values than the Southern
European countries. This finding is thought to result, in part,
from population-based differences in skin pigmentation, diets
rich in oily fish, the common use of cod-liver oil and a higher
degree of vitamin D supplementation in Scandinavian
countries(14,15). Although we did not find such a gradient in
the present review, we observed generally higher 25(OH)D
values in Swedish elderly than in those from other European
countries. Some have suggested that this finding can be
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explained by the routine fortification of oil and low-fat milk
products with vitamin D in Sweden(28).
In accordance with other reviews(5,8,15), our exploratory ana-
lyses also suggested that institutionalised elderly in Europe and
the Asia/Pacific region had lower mean 25(OH)D values than
the elderly living in the community. It is possible that such a find-
ing may result from less time spent outdoors due to poorer
health status(29), although similar findings in other groups of
institutionalised individuals could be expected elsewhere.
Further investigations of the patterns of vitamin D deficiency
and insufficiency are needed in this vulnerable subgroup.
Another interesting finding from our exploratory analyses was
that newborns/infants were reported to have lower 25(OH)D
values than the members of other age groups in several countries
worldwide. Because newborn vitamin D status is mainly deter-
mined by maternal vitamin D status(30), this finding may be
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Table 2. Effect estimators (ES) from the meta-analyses stratified by age and region*
(ES and 95 % confidence intervals)
Regions I 2 (%) n (studies) n (participants) ES 95 % CI
Europe
Children/adolescents (.1–17 years) 99·5 6 1816 50·56 34·35, 66·77
Adults (.17–65 years) 99·4 35 28 844 52·98 45·01, 56·58
Elderly (.65 years) 99·4 30 10 894 51·74 45·81, 57·66
North America
Children/adolescents (.1–17 years) 98·5 3 993 78·35 59·44, 97·25
Adults (.17–65 years) 99·7 8 6201 71·83 57·71, 86·00
Elderly (.65 years) 99·3 15 5307 71·70 64·84, 78·57
Asia/Pacific
Children/adolescents (.1–17 years) 85·4 3 899 31·89† 24·94, 38·84
Adults (.17–65 years) 99·5 13 3709 67·99 59·73, 76·25
Elderly (.65 years) 98·8 9 4965 66·16 62·16, 70·22
Middle East/Africa
Children/adolescents (.1–17 years) 99·2 6 1913 75·41† 56·43, 94·38
Adults (.17–65 years) 98·5 6 2079 34·66 29·32, 40·01
Elderly (.65 years) 99·2 4 874 38·20 29·15, 47·25
* Meta-analyses were not conducted for studies carried out in Latin America due to the limited number of eligible studies.
† Values were significantly different from those of the other age groups.
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explained by generally inadequate vitamin D levels in pregnant
women as suggested in previous work(31). Future research in
these groups is needed to confirm these findings and test inter-
ventions aimed at interrupting this putative mechanism.
Strengths and limitations
To our knowledge, the present systematic review, conducted in
accordance with the PRISMA statement(18), is among the first to
focus on patterns of vitamin D status worldwide and in key
population subgroups. We purposefully sought to identify
studies with randomly selected samples from the general popu-
lation to reduce sources of bias, which may otherwise obscure
the public health importance of vitamin D status across the
world. Use of continuous 25(OH)D values in our analyses is
another important strength of thepresent study, given the incon-
sistent application of thresholds to indicate 25(OH)Ddeficiency,
insufficiency and adequacy. A systematic search strategy based
on two of the largest biomedical literature databases also
reduced the probability of missing relevant articles. Besides
the detailed data on 25(OH)D values among important sub-
groups by age, sex and region, the present review adds to the
current understanding of vitamin D status in both developed
and developing countries worldwide. We used the random-
effects model to account for the substantial heterogeneity that
we observed across the studies. Between-study heterogeneity
is common in systematic reviews, especially in observational
epidemiology where unobserved characteristics at both the
study and individual levels affect the outcomes of interest. The
random-effects model adjusts for this heterogeneity by incor-
porating a between-study component of variance in the weights
used for calculating the summary estimate(32).
It is important to consider the findings of the present review
in the context of several potential limitations. First, we cannot
fully exclude publication bias as studies reporting vitamin D
deficiency might have been more likely to be published
than those reporting mean or median levels within the
normal range. Second, language bias may have affected the
results, as we limited the present review to articles written in
English. This may have accounted, for example, for the rela-
tive under-representation of studies conducted in Latin
America in our sample. Efforts to identify and review studies
published in languages other than English are needed in the
future to gain a clear understanding of the full scope of vita-
min D deficiency worldwide. Third, our strict inclusion criteria
(e.g. inclusion of studies with randomly selected samples)
might also explain the limited number of studies identified
from some regions. However, previous reviews using more
liberal inclusion criteria have also identified a limited
number of studies conducted in these regions(8,16). Fourth,
recruitment strategies in the studies that we sampled may
have focused to an extent on healthier populations, resulting
in an overestimation of the prevalence of adequate vitamin
D levels and a consequent minimisation of observable differ-
ences between the sexes or age-related subgroups. Fifth, we
observed substantial heterogeneity between the studies in
our sample that could not be explained by variables such as
age, sex, season, distance from the equator, assay type or
representativeness. Other unmeasured factors influencing vita-
min D status (e.g. dietary intake, clothing style, time spent out-
doors and use of sunscreen) may have contributed to the
heterogeneity of results. Differences across the studies in
study quality, adjustment for potential confounders and the
definition of some characteristics or factors such as season
may have contributed substantially to the heterogeneity that
we observed. Finally, the precision of the estimates of vitamin
D status in the subgroups of interest in the present review was
probably affected by their relative under-representation in
studies conducted in many regions of the world. High-quality
population-based studies that assess and report all relevant
data on 25(OH)D levels and central covariates including life-
style factors to enable comparison of 25(OH)D values in the
future, at least for population subgroups within the same
country, have to be conducted.
Conclusion
Although we found a high degree of variability in reports of
vitamin D status at the population level, more than one-third
of the studies in the present systematic review reported
mean 25(OH)D values below 50 nmol/l. Given the substantial
heterogeneity of published evidence to date, further research
on worldwide patterns of vitamin D deficiency at the popu-
lation level and within key subgroups is needed to inform
public health policy development to reduce risk for potential
health consequences of an inadequate vitamin D status. The
present review further suggests the importance of developing
and implementing research designs that minimise potential
sources of bias and consequently strengthen our understand-
ing on vitamin D status in key subgroups worldwide.
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